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ABSTRACT Oocyte maturation in all species is controlled by a protein complex termed the maturation
promoting factor (MPF). MPF comprises a cyclin-dependent kinase (CDK) and its partner cyclin, and it is
regulated by dueling regulatory phosphorylation events on the CDK. In Caenorhabditis elegans, the Wee1/
Myt1 ortholog WEE-1.3 provides the inhibitory phosphorylations on CDK-1 that keep MPF inactive and halt
meiosis. Prior work has shown that depletion of WEE-1.3 in C. elegans results in precocious oocyte maturation in vivo and a highly penetrant infertility phenotype. This study sought to further deﬁne the precocious maturation phenotype and to identify novel interactors with WEE-1.3. We found that WEE-1.3 is
expressed throughout the germline and in developing embryos in a perinuclear pattern, and demonstrated
that oocytes in WEE-1.3–depleted germlines have begun to transcribe embryonic genes and exhibit inappropriate expression of proteins normally restricted to fertilized eggs. In addition, we performed an RNAi
suppressor screen of the infertile phenotype to identify novel factors that, when co-depleted with WEE-1.3,
restore fertility to these animals. We screened 1900 essential genes by RNAi feeding and identiﬁed 44
(2% of the tested genes) that are suppressors of the WEE-1.3 depletion phenotype. The suppressors
include many previously unidentiﬁed players in the meiotic cell cycle and represent a pool of potential
WEE-1.3 interacting proteins that function during C. elegans oocyte maturation and zygotic development.

A basic tenet of reproductive biology is the conjoining of two haploid
gametes, an egg and a sperm, to form a diploid zygote. One major
difference between the two sexes is the method through which they
create a ﬁnal, functional haploid gamete. Both males and females generate haploid gametes via the meiotic cell cycle, which consists of one
round of DNA replication followed by two rounds of chromosome segregation. However, meiosis is differentially regulated in the two gametes.
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Spermatocytes, the precursors to sperm, proceed through meiosis
uninterrupted, whereas oocytes arrest during meiosis at a species-speciﬁc
stage. This arrest typically occurs at prophase I, and then later when the
female reaches reproductive maturity the oocytes are activated in a process referred to as meiotic maturation (Nebreda and Ferby 2000; Von
Stetina and Orr-Weaver 2011). During the arrest period, the oocytes
grow in size and accumulate all of the transcripts required to support
meiotic maturation and fertilization (Schindler 2011).
Oocyte meiotic arrest is maintained and cell-cycle proliferation is
inhibited until the oocyte receives an external hormonal stimulus that
alleviates the arrest and promotes oocyte maturation. Cyclin-dependent
kinases are the universal regulators of both mitotic and meiotic cellcycle progression in eukaryotes. A complex of cyclin-dependent kinase 1
(Cdk1) and its partner cyclin B, termed maturation promoting factor
(MPF), acts to drive the meiotic cell cycle (Doree and Hunt 2002;
Greenstein 2005; Kishimoto 2003). The activity of MPF is regulated
through phosphorylation, dephosphorylation, and cyclin degradation.
During meiotic arrest in vertebrates, the MPF complex must be kept in
an inactive state; this inhibition is accomplished via phosphorylations
on Thr14 (T14) and Tyr15 (Y15) residues of Cdk1 by the Wee1/Myt1
family of inhibitory kinases (Schmitt and Nebreda 2002). In addition, an
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activating phosphorylation event occurs on Thr161 (for human Cdk1)
by the Cdk-activating kinase CAK (CDK-7 in C. elegans) (Wallenfang
and Seydoux 2002). Dephosphorylation of T14 and Y15 on CDK-1
occurs by a dual-speciﬁc phosphatase, Cdc25, resulting in a functional
kinase and resumption of the meiotic cell cycle. Cyclin B is also targeted
for degradation by an ubiquitin-ligase known as the anaphase promoting complex (APC), enabling the transition from meiotic metaphase I to
anaphase I (Boxem 2006; Zachariae and Nasmyth 1999).
Once MPF is activated, a number of hallmark events occur that
deﬁne oocyte maturation in many species. These events include nuclear
envelope breakdown (NEBD), chromosome congression, rearrangement of the cortical cytoskeleton, and meiotic spindle assembly (Jones
2004; Von Stetina and Orr-Weaver 2011). In C. elegans, the hallmarks
of oocyte maturation have been shown to occur upon sperm signaling
and the presence of major sperm protein (MSP) (Miller et al. 2001;
Singaravelu and Singson 2011; Yamamoto et al. 2006). Interestingly, this
process of meiotic maturation is spatially restricted in the nematode
gonad to the 21 oocyte, the oocyte immediately adjacent to the spermatheca. Depletion of WEE-1.3, the Myt1 inhibitory kinase ortholog, in
C. elegans results in precocious oocyte maturation in vivo (Burrows
et al. 2006). The precociously maturing oocytes exhibit premature
NEBD, chromosome over-congression where the chromosomes have coalesced into a single mass of chromatin, aberrant meiotic spindle organization, and premature oocyte-to-embryo transition as evidenced by the
premature relocalization of MBK-2 in the WEE-1.3–depleted oocytes
(Burrows et al. 2006). These oocytes are ovulated and do encounter
sperm; however, they are fertilization-incompetent and the animals are
infertile (Burrows et al. 2006). Similarly, in vitro antibody depletion of
Myt1 in Xenopus oocytes results in precocious NEBD (Nakajo et al. 2000).
In this study, we sought to expand on the role that WEE-1.3 plays
in C. elegans oocyte maturation and further investigate the precociously
maturing oocytes exhibited upon depletion of WEE-1.3. We found that
WEE-1.3 depletion results in a premature oocyte-to-embryo transition
as demonstrated by the relocalization of maternal proteins within the
oocyte to embryonic patterns of distribution. In addition, the WEE1.3–depleted oocytes have undergone embryonic gene activation
(EGA), despite the fact that oocytes are normally transcriptionally quiescent and wild-type embryonic transcription is not reported to begin
until the four-cell embryo (Biedermann et al. 2009; Seydoux et al. 1996).
Finally, we performed an RNAi suppressor screen to identify factors
that, when co-depleted with WEE-1.3, resulted in restoration of fertility.
The 44 identiﬁed factors are potentially novel regulators and interactors
with WEE-1.3, but also could be regulators and interactors with CDK-1.
MATERIALS AND METHODS
Strains
Wild-type C. elegans was Bristol strain N2. All strains were grown
under standard conditions at 20 (Brenner 1974), except the WEE1.3–tagged transgenes, which were grown at 24 to visualize expression. A
list of all the strains used can be found in Table 1. Some nematode strains
used in this work were provided by the Caenorhabditis Genetics Center,
which is funded by the NIH National Center for Research Resources
(NCRR). The FIB-1::GFP transgenic strain (COP262) was generated using a custom transgenic service (Knudra Transgenics, Salt Lake City, UT).
Plasmid construction
All plasmids were constructed using PCR from genomic N2 DNA and
the Gateway cloning technology (Invitrogen, Grand Island, NY). The
sequences of all entry clones were conﬁrmed. The ﬁnal plasmids generated were pAA10 (wee-1.3 prom::GFP::WEE-1.3::wee-1.3 39UTR) and
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pAA34 (wee-1.3 prom::WEE-1.3::GFP::wee-1.3 39UTR). The promoter
sequence utilized in each construct is as follows: 1047 bp (for pAA10)
and 957 bp (for pAA34) upstream of the wee-1.3 translational start site.
The wee-1.3 39UTR is annotated in WormBase (release WS232) as
being 446 nucleotides long. We utilized a slightly longer piece of genomic DNA in the translational reporters to ensure proper expression
in vivo (523 bp downstream of the stop codon). The PCR products
were cloned into the entry vectors (Invitrogen, Grand Island, NY)
pDONR(P4-P1r) and pDONR(P2r-P3) as described in Supporting Information, Table S1 via a Gateway BP reaction. pAA10 was generated
through a MultiSite Gateway LR reaction utilizing the following plasmids: pAA11, pCR110, pAA15, and pCR319. pAA34 was generated
through a MultiSite Gateway LR reaction utilizing the following plasmids: pAA32, pCR110, pAA13, and pCR319. A description of all plasmids and primer sequences used can be found in Table S1.
CBD-1::mCherry construction
The entry clone containing the cbd-1 promoter and cbd-1 coding
sequences (exons and introns) was made as follows. N2 genomic lysates
were PCR-ampliﬁed with primers B4F2 and B1R3 (see Table S1 for
primer sequences). The 5.6-kb fragment was recombined into pDONR
P4P1R. This construct has 1169 bp of 59 UTR sequence. Sequencing
revealed an error at nucleotide #1921 (T/C nucleotide change; V/A
amino acid change), which was corrected with the QuikChange Mutagenesis kit (Agilent Technologies, Santa Clara, CA). The entry clone
containing the cbd-1 39 UTR was made as follows. N2 genomic lysates
were PCR-ampliﬁed with primers B2rF2 and B3R1. The 389-bp PCR
fragment was recombined into pDONR P2RP3. The expression clone
was constructed by performing a Gateway LR reaction with the above
two entry clones, pCR347 and pCR319.
FIB-1::GFP construction
DNA coding for the ﬁb-1 promoter, genomic sequence, and 39 UTR
was inserted into pCFJ151 (ttTi5606) targeting vector to make pNU162
(ﬁb-1 prom::FIB-1::eGFP::ﬁb-1 39UTR). pNU162 was microinjected into
EG6699 (ttTi5605) strain and MosSCI transgenic capture was performed
with mCherry markers. Isolates were screened, a single copy insertion at
Mos locus was determined via PCR, and the line COP262 was generated
(knuSi221 [pNU162 (ﬁb-1p::FIB-1::eGFP::ﬁb-1 39UTR, unc-119(+))] II ;
unc-119 (ed3) III). All services were performed by Knudra Transgenics
(Salt Lake City, UT).
C. elegans transformation
All transgenic lines, except for the FIB-1::GFP line described above,
were generated by microparticle bombardment as previously described,
except that animals were grown in liquid culture before transformation
(Praitis et al. 2001; Stein et al. 2010). For each construct, expression was
analyzed and found to be similar in at least ﬁve independent lines.
Speciﬁcally, a strain containing an integrated transgene, avIs147, and
a strain containing an extrachromosomal array, avEx148, are detailed in
this article. To determine if the transgenes could rescue the absence of
WEE-1.3, avIs147 (WEE-1.3::GFP) was crossed to the wee-1.3 deletion
line (VC465) to obtain a line that is homozygous for the deletion and
contains the transgene.
RNA interference
RNAi was performed via feeding as described using HT115(DE3) bacteria seeded on MYOB plates containing 2 mM IPTG and 25 mg/mL
carbenicillin (Timmons and Fire 1998). RNAi constructs were obtained
from the Open Biosystems library (Huntsville, AL), and the identity of
each suppressor clone was veriﬁed by sequencing. L4 hermaphrodites

n Table 1 Nematode strains used in this study
Name

Description

AG221

WEE-1.3::GFP

AG222

GFP::WEE-1.3

VC465

wee-1.3 deletion

JH1576

GFP::MBK-2

AD200

GFP::EGG-3

RT688

CAV-1::GFP

AD265

GFP::CHS-1

JJ2101

PGL-1::GFP

TX189

OMA-1::GFP

AG212

CBD-1::mCherry

OCF22

mCherry::NPP-1

OCF15

mCherry::SP12

AG223

WEE-1.3::GFP ;
mCherry::NPP-1

AG224

WEE-1.3::GFP ;
mCherry::SP12

COP262

FIB-1::GFP

OCF1

mCherry::Histone H2B

AG229

FIB-1::GFP ; mCherry::
Histone H2B

Genotype

Reference

unc-119(ed3); avIs147[pAA34 (unc-119(+) + wee-1.3
prom::WEE-1.3::GFP::wee-1.3 39UTR]
unc-119(ed3); avEx148[pAA10(unc-119(+) + wee-1.3
prom::GFP::WEE-1.3::wee-1.3 39UTR)]
wee-1.3(ok729)/mIn1[mIs14 dpy-10(e128)]
(1168bp deletion)
unc-119(ed3); axIs1140 [pJP1.02(unc-119(+) +
pie-1 prom::GFP::MBK-2)]
unc-119(ed3); asIs1[unc-119(+) + pie-1
prom::GFP::EGG-3]
unc-119(ed3); pwIs28[pie-1 prom::CAV-1::GFP::
pie-1 39UTR + unc-119(+)]
unc-119(ed3); nnIs2[unc-119(+) + pie-1
prom::GFP::CHS-1]
unc-119(ed3); zuIs242[unc-119(+) + nmy-2
prom::PGL-1::GFP::nmy-2 39UTR]
unc-119(ed3); teIs1[pRL475(oma-1 prom::OMA-1::GFP) +
pDPMM016(unc-119+)]
unc-119(ed3); avIs143 [pDNL10 (unc-119(+) + cbd-1
prom::CBD-1::mCherry::cbd-1 39UTR)]
unc-119(ed3); ocfIs5[unc-119(+) + pie-1
prom::mCherry::NPP-1::pie-1 39UTR]
unc-119(ed3); ocfIs2[unc-119(+) + pie-1
prom::mCherry::SP12::pie-1 39UTR]
unc-119(ed3); avIs147[pAA34 (unc-119(+) + wee-1.3
prom::WEE-1.3::GFP::wee-1.3 39UTR]; ocfIs5[unc-119(+) +
pie-1 prom::mCherry::NPP-1::pie-1 39UTR]
unc-119(ed3); avIs147[pAA34 (unc-119(+) + wee-1.3
prom::WEE-1.3::GFP::wee-1.3 39UTR]; ocfIs2[unc-119(+) +
pie-1 prom::mCherry::SP12:: pie-1 39UTR]
unc-119(ed3); knuSi221[pNU162 (ﬁb-1
prom::FIB-1::eGFP::ﬁb-1 39 UTR + unc-119(+)]
unc-119(ed3); ltIs37 [pAA64 (unc-119(+) + pie-1
prom::mCherry::his-58 39UTR)]
unc-119(ed3); knuSi221[pNU162 (ﬁb-1
prom::FIB-1::eGFP::ﬁb-1 39 UTR + unc-119(+)]; ltIs37
[pAA64 (unc-119(+) + pie-1 prom::mCherry::his-58 39UTR)]

were fed for 20–24 hr at 24 and then moved to a new RNAi plate for
another 20–24 hr (3 animals per plate). At the end of the second 24-hr
period, hermaphrodites were removed and either discarded or imaged
depending on the experiment. The second-day plate was scored 1 d later
to determine brood size and hatching data. As a control, worms were
fed bacteria expressing double-stranded RNA (dsRNA) against smd-1
(F47G4.7), which does not produce a visible phenotype. For combinatorial RNAi, bacterial cultures expressing the dsRNA were grown separately to saturation and mixed in equal volume amounts immediately
prior to seeding the plates. Brood size analysis was conducted by totaling
the number of embryos and larvae on the indicated plates.
Live imaging
Adult hermaphrodites of the appropriate genotype were picked onto a
slide with a 1% agar pad containing a drop of M9/0.2 mM levamisole. A
coverslip was then placed on top of the drop and sealed with nail polish.
Paralysis was allowed to set in for 10 min before imaging proceeded.
Animals were then imaged using the techniques described below in the
Microscopy section.
Immunoﬂuorescence
Adult hermaphrodites were picked into 100 mL of PBS/0.1% Tween20 (PBTw) in a deep watch glass, levamisole was added to a ﬁnal

This study
This study
CGC
Pellettieri et al. 2003
Maruyama et al. 2007
Sato et al. 2006
Maruyama et al. 2007
Wolke et al. 2007
Lin 2003
This study
Joseph-Strauss et al. 2012
Joseph-Strauss et al. 2012
This study

This study

This study
Golden et al. 2009
This study

concentration of 0.2 mM, and then the animals were dissected by cutting
off the heads at the level of the pharynx using 25-gauge syringe needles,
such that at least one gonad arm extruded completely. The animals were
ﬁxed in 2 mL of 3% PFA solution (3% formaldehyde/0.1 M K2HPO4/
0.1 M KH2PO4) for 10 min. After ﬁxation, an equal volume of PBTw
was added and the gonads were transferred to a 5-mL glass conical tube
before being centrifuged for 1 min on low speed in a clinical benchtop
centrifuge. Supernatant was discarded, and then the animals were
washed twice with PBTw and post-ﬁxed in ice-cold 100% methanol
for a minimum of 5 min. The tube was ﬁlled with PBTw, centrifuged
as described above, supernatant was removed, and animals were washed
three times with PBTw. After the third wash, animals were transferred to
a small glass culture tube (Kimble Chase #73500650, Vineland, NJ) and
allowed to settle before most of the liquid was aspirated and samples
were blocked in PBTw containing 30% normal goat serum (NGS) for
1 hr at room temperature. The block was removed, samples were washed
in PBTw, primary antibodies were added, and samples were put at 4 for
16–20 hr. The supernatant was removed, samples were washed three
times in PBTw for 5 min each, and secondary antibodies were added for
2 hr at room temperature in the dark. Removal of the supernatant was
followed by three 5-min washes in PBTw, with the last wash containing
100 ng/mL DAPI. Vectashield (Vector Laboratories, Burlingame, CA)
and the samples were transferred to a large 2% agar pad on a standard
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microscope slide. Excess liquid was withdrawn with a capillary, and an
eyelash hair was used to manipulate and position gonads. A large coverslip was placed on top of the samples and sealed with nail polish. Slides
were allowed to rest for at least 1 hr in the dark before they were imaged.
Primary antibodies were diluted in PBTw as follows: rabbit antiphospho-histone H3(Ser10) (1:200; Upstate Biotechnology, Waltham,
MA), mouse anti-Nop1p (1:100; EnCor Biotech, Alachua, FL), and
mouse anti-WEE-1.3 (1:500; this study). Secondary antibodies were
Alexa Fluor 448–conjugated or Alexa Fluor 568–conjugated goat antirabbit or goat anti-mouse (1:1000; Invitrogen, Grand Island, NY).
Generation of anti-WEE-1.3 antibody
A monoclonal mouse antibody to WEE-1.3 (ab4D5) was generated using
a custom antibody service (Abmart, Shanghai, CH) to the C-terminal
peptide sequence DLPRMPVLNF.
Microscopy
Fluorescent images of live or ﬁxed samples were captured either using
spinning-disk confocal microscopy as described previously in Golden
et al. (2009) or using a Nikon Ti-E-PFS inverted microscope equipped
with a 60· 1.4NA Plan Apo Lamda objective. The Ti-E-PFS system is
outﬁtted with a Yokogawa CSU-X1 spinning disk unit, a self-contained
four-line laser module (excitation at 405, 488, 561, and 640 nm), and
Andor iXon 897 EMCCD camera. Confocal images were acquired using
Openlab 4.0 or NIS-Elements and processed using ImageJ 1.38X and
Adobe Photoshop CS5 software. All images shown are single focal
planes unless noted.
RNAi suppressor screen
1874 RNAi clones within the Open Biosystems collection that had
been reported on WormBase (release WS232) as having an embryonic
lethal phenotype (EMB) were screened to determine if they suppressed the WEE-1.3-depletion phenotype (Harris et al. 2010; Kamath
et al. 2003; Sonnichsen et al. 2005). RNAi was performed as described
above. For combinatorial RNAi, bacterial cultures expressing the
dsRNA were grown separately and mixed in equal volume amounts
immediately before seeding the plates. Controls included were: control
(smd-1) RNAi; cdk-1 RNAi; wee-1.3 RNAi; co-depletion of wee-1.3
and smd-1; and co-depletion of wee-1.3 and cdk-1.
In phase I, suppression was scored visually based on appearance of
progeny on the plate. Clones that failed to suppress had plates with no
progeny; weak suppressors had plates with ,10 embryos; moderate
suppressors had plates with ,50 embryos and, in some cases, a few
larvae; and strong suppressors had plates with .50 larvae that, in
some instances, developed into adult animals. All candidate suppressors
were then retested to ensure accuracy in visual scoring, tested to see if
they were global suppressors of RNAi utilizing combinatorial RNAi
with lit-1 and each potential suppressor, and sequenced using an M13
forward primer to verify their identities along with a subset of nonsuppressing candidates (n = 42). Approximately 6% of the 193 sequenced
clones from the library did not show any homology to C. elegans genes by
BLAST. All unconﬁrmed clones are noted in Table S2.
In phase 2, quantiﬁcation of 52 of the 57 identiﬁed moderate and
strong candidate suppressors was conducted (see Table S2, “Quantiﬁed
Suppressors”). RNAi clones were re-transformed into HT115(DE3) and
RNAi was conducted as above, with the exception that single L4 hermaphrodites (n = 12) were placed on individual plates to determine
brood size per individual animal. At least three independent experiments
were conducted for each condition, and then the average brood size,
percent hatching, and SEM for each RNAi treatment was determined as
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described above. The total number of hermaphrodites tested for each
RNAi treatment was between 24 and 100 animals. Statistics were performed using a Student’s t-test and comparing candidate suppressor
brood results with the brood exhibited by wee-1.3/control RNAi-treated
animals.
Gene ontology analyses
Functional enrichment was assessed using the DAVID database
(http://david.abcc.ncifcrf.gov/). The suppressors were analyzed for
GOTERM_BP_5 and GOTERM_CC_5 through functional annotation
clustering using medium classiﬁcation stringency with a similarity
threshold of 0.50. The statistical signiﬁcance threshold level for all gene
ontology enrichment analyses was P , 0.05 (Huang et al. 2009a,b).
Quantiﬁcation of mRNAs in dissected gonads
Total RNA was isolated from 100 dissected gonads per RNAi treatment using the Arcturus PicoPure RNA Isolation Kit (Applied Biosystems, Foster City, CA). Dissected gonads consisted of the gonad
region from the distal tip to the spermatheca, but did not contain any
portion of the uterus or embryos. Isolation included the optional
DNase treatment to remove DNA contamination. Real-time PCR reactions were performed in triplicate using 5 ng of template RNA, Quantifast SYBR Green RT-PCR Kit (Qiagen, Valencia, CA), and appropriate
primers in an ABI 7900HT Fast Real-Time PCR detection system (Applied Biosystems, Carlsbad, California) according to the manufacturer’s
instructions. Amplicons were designed, when possible, to span one or
more introns to avoid ampliﬁcation of the target gene in genomic DNA.
For primer sequences, see Table S1. PCR reactions were performed as
follows: 10 min at 50, 5 min at 95, then 40 cycles of 10 sec at 95 and
30 sec at 60. Each PCR reaction then concluded with determination of
the melting curve of the amplicon to verify ampliﬁcation of only one
product. A no reverse transcriptase control was performed for each
tested RNA and a nontemplate control was performed for each primer.
Average Ct values were determined by the SDS v2.3 software for each
primer pair. Fold change was calculated using the comparative Ct
(DDCt) method where values for a particular transcript were normalized to an endogenous control within each sample (act-1 mRNA levels)
and then normalized to the calibrator sample (control RNAi gonads).
Error bars show the SEM for the replicates.
RESULTS
WEE-1.3 is ubiquitously expressed and perinuclear
We examined the expression pattern of WEE-1.3 by constructing
translational fusion transgenes and generating transgenic animals.
Both N- and C-terminally tagged GFP and mCherry transgenes that
contained the endogenous wee-1.3 promoter, full-length wee-1.3 sequence, and wee-1.3 39UTR were created, and multiple transgenic lines
were generated by microparticle bombardment (Praitis et al. 2001). In
total, 12 extrachromosomal lines (7 N-terminally tagged, 5 C-terminally
tagged) and 10 integrated lines (6 N-terminal tagged, 4 C-terminally
tagged) were generated, of which 11 and 7, respectively, resulted in
strong expression (data not shown). All expressing transgenes exhibited
similar patterns; as such, only two lines are detailed here, avIs147 and
avEx148, henceforth referred to as WEE-1.3::GFP or GFP::WEE-1.3,
respectively. WEE-1.3::GFP expression is perinuclear throughout the
adult soma, germline, and within developing embryos (Figure 1). Perinuclear expression is observed from the distal tip of the germline to the
mature proximal oocytes (Figure 1A, asterisk and arrowhead, respectively). It then continues to be expressed in developing embryos within
the uterus of the animal (Figure 1A arrow, Figure 1D). In addition to

the perinuclear expression within the germline, there is some diffuse
cytoplasmic expression within developing oocytes and embryos, expression on the membrane within developing oocytes and embryos, and
distinct punctae on the surface of the oocytes (Figure 1B) and within
embryos (Figure 1D). The spermatheca of hermaphrodites of avEx148,
along with other extrachromosomal lines (7 of 12) and some integrated
lines (3 of 7), exhibit GFP::WEE-1.3 within sperm (Figure 1C). In the
somatic tissues of the adult, perinuclear WEE-1.3::GFP expression is
observed throughout the adult, including nuclei of the head (Figure
1E) and tail (Figure 1F). The nuclei of many cell types in the developing
larvae, including the cells of the developing intestine (Figure 1G), also
exhibit WEE-1.3::GFP expression. Importantly, avIs147 rescued the
wee-1.3(ok729) deletion mutant to viability and therefore is believed
to make functional WEE-1.3 protein (Figure 1, B, D–G).
Subcellular localization of WEE-1.3::GFP was shown to be
perinuclear through colocalization studies with a tagged version of a
known nucleoporin protein, mCherry::NPP-1, that is localized to the
nuclear envelope (Figure S1, A–C) (Joseph-Strauss et al. 2012; Schetter
et al. 2006). In addition, WEE-1.3::GFP appears to be localized to the
endoplasmic reticulum (ER) through colocalization with a tagged version of a known ER marker, SP12 (Figure S1D–I) (Rolls et al. 2002).
WEE-1.3::GFP does not colocalize with the entire endoplasmic reticulum, as was shown through RNAi experiments involving lpin-1. In
animals fed control RNAi, the ER appears as a network of ﬁne tubules
with occasional small patches (Figure S1E), and WEE-1.3::GFP has a substantial amount of overlap with the ER marker SP12 (Figure S1F).
However, when the ER is disrupted using RNAi to lpin-1, the formation
of ER-like membrane sheets, patches, and vesicle-like structures appear
(Figure S1H) (Golden et al. 2009). In lpin-1–RNAi treated animals,
WEE-1.3::GFP does not colocalize with all regions of the expanded
and disorganized ER membrane (Figure S1I).
WEE-1.3 coats the diakinetic chromosomes
We generated a mouse monoclonal antibody to WEE-1.3 (mAb4D5)
that conﬁrmed all the expression patterns indicated by the various
integrated and extrachromosomal WEE-1.3 transgenic lines (data not
shown). In addition, this antibody appears to coat the diakinetic chromosomes found in the mature oocytes (Figure 1H, arrow). This can be
seen through co-staining for phospho-histone H3 (Ser10), a known
marker for condensed chromatin that is expressed in only mature
oocytes, and DAPI for DNA (Figure 1K). The WEE-1.3 expression is
observed within the nucleus of mature oocytes and appears to surround
the individual chromosomes.
Precocious oocyte-to-embryo transition occurs in
animals depleted of WEE-1.3
After an oocyte has been fertilized, a dynamic process referred to as
the oocyte-to-embryo (OTE) transition occurs. During the OTE transition, a number of proteins (such as EGG-4/5, EGG-3, MBK-2, and
CHS-1) exhibit dramatic changes in their localization pattern (Parry
and Singson 2011). EGG-4/5 proteins are cortical in late oocytes and
become diffusely cytoplasmic in embryos. EGG-3, MBK-2, and CHS-1
are also cortical in late oocytes; however, these proteins relocalize to
discrete cytoplasmic punctae in the embryo.
Depletion of WEE-1.3 has been previously shown to cause premature relocalization of EGG-4/5, EGG-3, CHS-1, and MBK-2 in the
oocytes from the cortex to a diffuse cytoplasmic pattern (EGG-4/5) or
to discrete cytoplasmic punctae (EGG-3, CHS-1, and MBK-2) (Cheng
et al. 2009; Stitzel et al. 2007). Conversely, the CAV-1 protein, which
is localized to punctae in oocytes and relocalizes to the cortex in
embryos, was reported to not exhibit premature relocalization to the

cortex of oocytes on WEE-1.3 depletion (Bembenek et al. 2007). To
further characterize the precocious oocyte maturation phenotype in
animals depleted of WEE-1.3, we examined additional proteins that
had been identiﬁed as having distinct localization patterns in the
oocyte vs. the embryo.
We were able to conﬁrm that GFP::MBK-2, GFP::EGG-3, and
GFP::CHS-1 all relocalized precociously to internal punctae in wee-1.3
(RNAi) oocytes, whereas CAV-1::GFP appeared normal in treated
oocytes (Figure 2, A–H). PGL-1, a known P-granule component, is
localized to cytoplasmic punctae that concentrate perinuclearly in
oocytes and very early embryos. This protein then undergoes degradation in all cells of the developing embryo except the P4 (germline)
blastomere (Kawasaki et al. 2004). PGL-1::GFP was degraded prematurely in the oocytes of wee-1.3(RNAi) animals compared with oocytes
of control animals (Figure 2, I–J). OMA-1 is another protein that is
expressed throughout the cytoplasm of maturing oocytes (with levels
peaking in oocytes undergoing maturation). Then, in early embryos,
OMA-1 becomes localized to discrete punctae before it is rapidly degraded by the four-cell stage (Detwiler et al. 2001). Upon depletion of
WEE-1.3, we observed the premature appearance of a large number of
discrete punctae in the oocytes (Figure 2, K and L, compare brackets) and
occasional oocytes undergoing premature degradation of OMA-1::GFP
(Figure 2L, arrows).
The chitin-binding domain protein CBD-1, a component of the
eggshell, has been previously reported to localize around oocytes
in the proximal germline (Johnston et al. 2010). Our data using
a CBD-1::mCherry transgenic animal generated for this study conﬁrm
that localization but also demonstrate that the level of CBD-1 on the
cortex of the oocytes is substantially reduced compared with the level
observed after fertilization and establishment of the eggshell in the
developing embryos (Figure 2M). Interestingly, CBD-1::mCherry is
prematurely expressed in WEE-1.3–depleted oocytes when compared
with expression in control oocytes (Figure 2, M and N). Taken together,
the above results suggest that the oocytes formed upon WEE-1.3 depletion exhibit multiple hallmarks of having precociously proceeded
through the oocyte-to-embryo transition.
To identify the earliest time point at which this precocious oocyteto-embryo transition occurs, we generated an animal that possessed
both ﬂuorescently tagged nucleoli and histones (FIB-1::GFP; Histone
H2B::mCherry) (Figure 2, O and P). The absence of a nucleoli, as
evident by no Nop1p staining, and the presence of condensed chromosomes, as evident by positive staining for phospho-histone H3 (pH 3),
are two markers by which precocious oocyte maturation has been characterized and observed in WEE-1.3–depleted animals (Burrows et al.
2006). The FIB-1::GFP; Histone H2B::mCherry animals allowed us to
determine via live imaging that after 16 hr of feeding of WEE-1.3 RNAi,
the nucleoli within a number of proximal oocytes begins to break-down,
as observed by an absence of FIB-1::GFP spots within the nucleus (Figure
2P, bracket). This is in stark contrast to what is observed in control
animals, where only the 21 oocyte lacks a nucleolus (Figure 2O, bracket).
This animal affords us the opportunity to observe when precocious oocyte
maturation is starting vs. examining the ﬁnal output of precocious oocyte
maturation, infertility.
Embryonic gene activation occurs in oocytes of animals
depleted of WEE-1.3
The premature relocalization of a subset of proteins within the WEE-1.3depleted oocytes led us to question whether those oocytes had undergone
embryonic gene activation (EGA) (Baroux et al. 2008; Edgar et al. 1994).
Oocytes are transcriptionally quiescent, and it is only after fertilization,
upon the oocyte-to-embryo transition, that transcription begins. This
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Figure 1 WEE-1.3 is expressed throughout the adult soma, germline, and embryos. (A–G) Fluorescence micrographs of live animals expressing
integrated transgene avIs147 [unc-119(+) + pAA34(wee-1.3 prom::WEE-1.3::GFP::wee-1.3 39UTR)] or an extra chromosomal array of avEx148
[unc-119(+) + pAA10(wee-1.3 prom::GFP::WEE-1.3 + wee-1.3 39UTR)]. (A) Adult hermaphrodite exhibits perinuclear WEE-1.3::GFP expression in
the germline from the distal tip (asterisk) to the proximal oocytes (arrowhead) and in developing embryos (arrows) [avIs147 (pAA34)]. Spermatheca
(SPTH) is indicated by the bracketed region. Note the distal tips from both gonad arms are shown in this image. (B) Punctate expression of WEE1.3::GFP on the surface of oocytes in the proximal germline of a rescued wee-1.3 deletion line [wee-1.3(ok729); avIs147 (pAA34)]. (C) Sperm
expression (arrow) of GFP::WEE-1.3 in the spermatheca of an avEx148 animal (pAA10). (D) Perinuclear and punctate expression of WEE-1.3::GFP
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process is termed embryonic gene activation. In C. elegans, embryos do
not begin transcribing mRNAs until they have reached the four-cell
embryo stage, and EGA is characterized by the transcription of several
very early transcripts (e.g., vet-1, vet-4, and vet-6) (Schauer and Wood
1990; Seydoux et al. 1996). To determine if WEE-1.3–depleted oocytes
exhibit precocious onset of EGA, we performed quantitative RT-PCR to
compare the levels of vet-1, vet-4, and vet-6 mRNAs in gonads dissected
from control(RNAi) or wee-1.3(RNAi) animals.
To determine that we were successfully depleting animals of WEE1.3, we ﬁrst analyzed the abundance levels of wee-1.3 mRNA in the
gonads of control(RNAi) and wee-1.3(RNAi) animals and found a 4.7fold decrease in mRNA levels upon treatment with wee-1.3(RNAi)
(Figure 3). We found that wee-1.3(RNAi) gonads had higher levels
of vet-1 and vet-4 than the control(RNAi) gonads, with two-fold and
four-fold enrichment, respectively (Figure 3). This suggests that the
unfertilized oocytes have undergone precocious EGA. Notably, the levels of vet-6 mRNA were not signiﬁcantly different between the control
(RNAi) and wee-1.3(RNAi) gonads (Figure 3), suggesting that wee-1.3
(RNAi)-treated gonads express some, but not all, of the mRNAs normally transcribed in the early embryo.
An RNAi screen identiﬁes 44 suppressors of the
WEE-1.3 depletion phenotype
Previously, we described the WEE-1.3 RNAi depletion phenotype as
infertility. RNAi-treated hermaphrodites exhibit precocious oocyte
maturation as characterized by a variety of oocyte maturation markers
(our results; Burrows et al. 2006). This phenotype could be suppressed
by the co-depletion of CDK-1 and WEE-1.3, resulting in broods of
more than 100 one-cell arrested embryos, whereas co-depletion of an
unrelated dsRNA (zyg-1) did not suppress the infertility of WEE-1.3
depletion (Burrows et al. 2006). To identify other WEE-1.3 interactors
and additional genes involved in oocyte maturation, we performed an
RNAi suppressor screen using the embryonic lethal (EMB) clones in
the OpenBiosystem RNAi library (Reboul et al. 2003; Rual et al. 2004).
EMB clones were chosen as a subset of the genome to screen because
null mutants of wee-1.3 are late embryonic or L1 lethal, and we reasoned
that any interacting gene might also be involved in early embryogenesis
and could potentially be embryonic lethal when depleted. Eventually,
after screening this subset of the genome, we intend to go back and
screen the entirety of the genome in a similar manner. We speciﬁcally
chose to use a double RNAi screen to identify interactors and/or regulators of WEE-1.3 due to the fact that there are no hypomorphic alleles of
wee-1.3 to suppress and dominant mutants for wee-1.3 have only a sperm
phenotype (Lamitina and L’Hernault 2002). In addition, RNAi of wee-1.3
in L4 animals is the only method through which the precocious oocyte
maturation and sterile phenotype can be observed because WEE-1.3 is
required for larval development.
We screened 1874 EMB clones from the library, which represent
1722 unique genes, or 8%, of the 20,553 protein-coding genes of
C. elegans (as of WormBase WS232). The genes we screened were
ones that had been classiﬁed as having an Emb phenotype through
any RNAi assay (feeding, soaking, or injecting) on WormBase. From
these, in phase 1 of the screen, we identiﬁed 150 potential suppressors

(plus one nonspeciﬁc suppressor; see below) of the WEE-1.3 RNAi
phenotype that, when co-depleted, resulted in restoration of fertility.
The suppressors differed in their ability to suppress the WEE-1.3
RNAi-induced infertility and were classiﬁed according to the level
of suppression as none, weak, moderate, or strong (Figure 4A). Of
the clones tested, 1723 (92%) failed to suppress, 94 (5%) weakly suppressed, 47 (2.5%) moderately suppressed, and 10 (0.5%) strongly
suppressed the infertility phenotype. An entire list of suppressing
clones can be found in Table S2. All of the suppressing clones were
sequenced to verify the RNAi clone tested (Table S2).
To determine whether the candidate suppressors exhibit speciﬁc
suppression of wee-1.3 or are global suppressors of RNAi, we asked if
any could suppress the embryonic lethality phenotype associated with
lit-1 RNAi treatment. Only one clone suppressed both the wee-1.3 and
lit-1 RNAi depletion phenotypes (data not shown). That gene was
sago-2, which encodes an Argonaute homolog that is partially required
for the ampliﬁcation phase of the RNAi response (Table 2 and Table S2)
(Yigit et al. 2006). All of the remaining 150 suppressors were speciﬁc for
wee-1.3(RNAi).
Co-depletion of CDK-1 and WEE-1.3 has been shown to suppress
the infertility of WEE-1.3 depletion alone (Burrows et al. 2006). Our
screen, which was performed blindly, successfully identiﬁed this known
suppressor in three separate tests (the cdk-1 feeding construct was
present in the library as three separate clones). Furthermore, the degree
of suppression was reproducible, as CDK-1 was classiﬁed as a moderate
suppressor in each instance (Table S2).
In phase 2 of the screen, we sought to quantify the degree of
suppression exhibited by the moderate and strong candidate suppressors (n = 51) and determine the average brood size upon suppression of
the WEE-1.3 depletion infertility (Figure 4B). Only 51 of the total 57
moderate and strong suppressors were tested because the remaining six
either represented duplicate RNAi clones in the library or repeatedly
failed to grow during phase 2 of the screen. Quantiﬁcation allowed us to
identify two different classes of suppressors: those that suppressed to
a wild-type level of fertility (n = 3, red bars, Figure 4B) and those that
suppressed the infertility phenotype associated with WEE-1.3 depletion
but did not restore fertility to a wild-type level (n = 48, gray bars, Figure
4B). Six of the 51 potential candidate suppressors were determined to
have no signiﬁcant difference in brood size of animals co-depleted of
wee-1.3 and the control gene, and one candidate, sago-2, was determined to be a global RNAi suppressor, as mentioned above (Figure 4B).
This analysis provided an additional way to categorize the suppression data by determining the percent hatching exhibited by animals
co-depleted of WEE-1.3 and a candidate suppressor. Our initial expectation was that if the sterility was suppressed, then complete embryonic
lethality would result because we know that wee-1.3 mutants are embryonic lethal and all the candidates tested were also reported to be
embryonic lethal. However, for many of the candidates tested in phase
2, a portion of the laid embryos successfully hatched into larvae (Table
2). The percent hatching was between 2% and 40% for all candidates,
with the sole exception being sago-2 with 95% hatching. Twenty-seven
out of the 44 suppressors (61%) exhibited hatching percentages less
than 20% (Table 2).

throughout developing embryos of a rescued wee-1.3 deletion line [wee-1.3(ok729); avIs147 (pAA34)]. (E) Somatic head nuclei expressing WEE1.3::GFP in a rescued wee-1.3 deletion line [wee-1.3(ok729); avIs147 (pAA34)]. (F) Somatic tail nuclei expressing WEE-1.3::GFP in a rescued wee1.3 deletion line [wee-1.3(ok729); avIs147 (pAA34)]. (G) Larval somatic expression of WEE-1.3::GFP in a rescued wee-1.3 deletion line [wee-1.3
(ok729); avIs147 (pAA34)]. (H–K) Z-stack projections of confocal images of gonads dissected from wild-type mothers, ﬁxed, and co-stained with
antibodies against WEE-1.3 (H, red in K), phospho-histone H3 (Ser10) (I, green in K), and DNA (J, blue in K). The arrow in (H) indicates WEE-1.3
expression that coats the diakinetic chromosomes in mature oocytes. Scale bars are approximately 20 mm.
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Figure 2 Precocious oocyte-to-embryo transition upon WEE-1.3 RNAi depletion. (A–N) Single confocal images of live wild-type (A, C, E, G, I, K,
and M) or wee-1.3(RNAi) (B, D, F, H, J, L, and N) hermaphrodites expressing GFP::MBK-2 (A, B), GFP::EGG-3 (C, D), CAV-1::GFP (E, F), GFP::CHS-1 (G, H),
PGL-1::GFP (I, J), OMA-1::GFP (K, L), or CBD-1::mCherry (M, N). Brackets in (K and L) denote OMA::GFP localizing to discrete punctae. Arrows in (L)
denote oocytes undergoing premature degradation of OMA-1::GFP. (O and P) Z-stack projections of live images of FIB-1::GFP; Histone H2B::mCherry
hermaphrodites (FIB-1 in green and histones in red). Asterisk denotes the position of the spermatheca with oocytes to the left of the spermatheca and
embryos to the right. Bracket in (O and P) denote mature oocytes. Scale bar in (A) applies to (A–J) and (M–P), and is approximately 20 mm. Scale bar in (K)
applies to (K and L) and is approximately 20 mm. More than 20 animals were observed and imaged for each condition, and a representative image is
shown.
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Figure 3 Depletion of WEE-1.3 results in precocious onset of embryonic gene activation. The
expression of the three mRNAs, vet-1, vet-4, and
vet-6, is normally restricted to the early embryo;
however, in gonads subjected to wee-1.3(RNAi)
they are expressed precociously in the gonad. The
graph shows the relative amounts of the indicated
mRNAs, determined by quantitative RT-PCR, found
in the gonads of adults subjected to either control
or wee-1.3 RNAi. Relative abundance for each target gene on wee-1.3 RNAi treatment was calculated using the comparative Ct (DDCt) method in
which values were ﬁrst normalized to act-1 mRNA
levels and then normalized to the calibrator sample
(control RNAi gonads). Each bar represents the
mean of three independent biological replicates,
and the error bars represent SEM. Statistics were
performed using a Student’s t-test. P-value ,0.05;
P-value ,0.01; and P-value #0.0001.

Through the two phases of the RNAi screen, we identiﬁed 44
potential suppressors of the WEE-1.3 depletion infertility, of which 43
were novel suppressors (Table 2). The one exception was cdk-1, which
had been previously shown to suppress wee-1.3(RNAi).
GO analysis of potential suppressors
To identify functional themes among the wee-1.3 RNAi suppressors,
we searched for enriched gene ontology (GO) annotations (Figure S2)
using the DAVID bioinformatics comparison tool (Huang et al. 2009a,
b). This strategy allowed us to identify sub-ontologies within both the
biological process (BP) and cellular component (CC) gene ontology

categories that were speciﬁcally enriched in our dataset of candidate
suppressors. Enrichment values within the BP category were for genes
involved in tissue morphogenesis, meiosis/mitosis, nuclear migration,
and RNA processing. Within the CC category, enrichment values were
for intracellular organelle/nucleus and proteasome complex.
Co-depletion of CDK-7 and WEE-1.3 suppresses the
WEE-1.3 depletion phenotype
CDK-7 has been shown to function in C. elegans as a CDK-activating
kinase (CAK) essential for cell-cycle progression (Figure 5A) (Wallenfang
and Seydoux 2002). This kinase phosphorylates a key residue on CDK-1,

Figure 4 Suppression screen of the WEE-1.3 RNAi infertility results in the identiﬁcation of 44 candidate suppressors. (A) Pie chart summarizing the suppression
screen data in which 1874 RNAi clones were screened to identify suppressors of the WEE-1.3 infertility phenotype. 92.0% (n = 1723) failed to suppress, 5.0%
(n = 94) weakly suppressed, 2.5% (n = 47) moderately suppressed, and 0.5% (n = 10) strongly suppressed the WEE-1.3 RNAi depletion infertility phenotype. (B)
Quantiﬁcation of the degree of suppression of 51 of the moderate and strong candidates identiﬁed in Figure 4A. Average brood size per individual mother
treated with wee-1.3(RNAi), control(RNAi), or co-depleted of wee-1.3 and candidate suppressor RNAi. Class 1 suppressors are denoted by a red bar and class 2
suppressors are denoted by a gray bar. Each bar represents the average of at least three independent experiments, and the errors bars represent SEM. The total
n per each condition was at least 24 and at most 100 animals. Statistics were performed using a Student’s t-test; all values are P-value ,0.005 when compared
with the brood exhibited by wee-1.3/control RNAi-treated animals, except P-value ,0.05; n.s. indicates not signiﬁcant. Indicates a global RNAi suppressor.

Volume 4 December 2014 |

C. elegans WEE-1.3 Suppression Screen | 2337

n Table 2 The 44 identiﬁed suppressors in the WEE-1.3 RNAi screen
Average Brood Sizea

Average Hatching %a

Predicted Function

sago-2b

153.9

95.50

cdk-7
cdk-1
snr-1

136.2
132.8
86.5

6.66
1.69
11.60

Y49E10.21
B0336.7
rpn-9

65.7
64.8
51.6

38.21
30.16
3.85

rpn-8
unc-97

32.5
32.4

2.32
33.56

attf-2
R10H10.3
msh-6
rpt-5

30.2
26.9
25.8
25.4

27.29
31.13
22.71
7.92

bir-2
rpn-2

22.7
21.4

30.81
4.65

etr-1
rpn-6.1

21.3
19.9

19.15
0.75

F36A2.7
acdh-12

18.5
17.8

27.28
17.34

acr-23

17.2

25.38

F11A3.2
C18E3.9
cul-2
prx-5

15.6
15.4
15.0
14.3

31.03
16.80
6.02
15.18

mop-25.3
C47E8.4
K04H4.2
C14B9.2
unc-11
taf-1
B0280.9
sel-8
imb-2
grk-1

12.3
12.3
11.9
11.3
11.1
10.4
10.3
10.2
10.1
9.1

24.28
21.08
25.69
11.77
25.70
9.75
13.91
18.25
11.81
23.40

inx-14
F42H10.5
cogc-2

8.6
7.9
6.8

10.10
15.39
11.37

sex-1

6.4

16.52

F02A9.4

5.8

25.10

henn-1
sdz-24

5.7
4.8

30.06
13.17

glr-6
mrps-30
C36E8.1
nud-1

4.5
4.4
4.2
3.3

9.62
7.88
16.55
11.49

Argonaute homolog partially required for the ampliﬁcation
phase of RNAi responses
Cyclin-dependent kinase
Cyclin-dependent kinase
Ortholog of human small nuclear ribonucleoprotein SmD3,
biogenesis and function of snRNPs
Novel protein of unknown function
Protein with a THAP or THAP-like domain
Non-ATPase subunit of the 19S regulatory
complex of the proteasome
26S proteasome regulatory complex, subunit RPN8/PSMD7
LIM domain-containing protein of the PINCH family,
highly similar to human LIMS1 and LIMS2
AT hook Transcription Factor family
C-type lectin
Mismatch repair ATPase MSH6
Triple A ATPase subunit of 26S proteasome’s 19S regulatory
particle (RP) base subcomplex
Protein with two BIR domains that may be involved in apoptosis
Non-ATPase subunit of the 26S proteasome’s 19S regulatory
particle (RP) base subcomplex
Muscle-speciﬁc ELAV-type RNA-binding protein
Non-ATPase subunit of the 19S regulatory complex of
the proteasome
Novel protein of unknown function
Orthologous to the human gene ACYL-CoA DEHYDROGENASE,
VERY LONG-CHAIN
Subunit of the nicotinic acetylcholine receptor which encode
ligand-gated ion channels
Translation initiation factor, guanine nucleotide exchange factor
Novel protein of unknown function
E3 ubiquitin ligase
Ortholog of the human receptor for type I peroxisomal
targeting signal protein, PXR1 (or PEX5)
Divergent ortholog of ﬁssion yeast Mo25p and budding yeast Hym1p
Conserved protein that is a member of the FAM50A/XAP5 family of proteins
Secreted protein with an N-terminal chitin-binding peritrophin-A domain
Protein disulﬁde isomerase (prolyl 4-hydroxylase beta subunit)
Clathrin-adaptor protein that functions in clathrin-mediated endocytosis
Transcription initiation factor
Novel protein of unknown function
Nuclear protein required for GLP-1 and LIN-12 signaling
Importin beta family protein
Serine/threonine protein kinase, most closely related to G
protein-coupled receptor kinases
Member of the innexin family
Novel protein of unknown function
Ortholog of mammalian COG-2, a subunit of lobe A of the
conserved oligomeric Golgi complex
DNA-binding protein, nuclear hormone receptor superfamily of
transcriptional regulators
Orthologous to human SIMILAR TO METHYLCROTONOYL-COENZYME
A CARBOXYLASE 2 (BETA)
HEN1 ortholog, RNA 39 end methyltransferase
SKN-1 Dependent Zygotic transcript, single-stranded DNA-binding
replication protein A
Putative non-NMDA ionotropic glutamate receptor subunit
Mitochondrial 28S ribosomal protein S30
Novel protein of unknown function
Nuclear distribution protein

Gene

a
reported averages for animals co-depleted of WEE-1.3 and the indicated candidate gene
b

sago-2 is a global RNAi suppressor that acts by reducing RNAi efﬁcacy and therefore is not considered a true suppressor.

2338 |

A. K. Allen, J. E. Nesmith, and A. Golden

the CDK component of maturation promoting factor (MPF), which is
required to make a functional, active MPF. Severe loss of cdk-7 activity,
accomplished through cdk-7(RNAi) feeding to animals homozygous for
the mutant allele cdk-7(ax224), led to a one-cell embryonic arrest
phenotype, similar to CDK-1 loss-of-function (Burrows et al. 2006;
Wallenfang and Seydoux 2002). In our suppressor screen, CDK-7
was identiﬁed as a moderate suppressor of the WEE-1.3 depletion infertility phenotype (Table S2).
To show this quantitatively, we conducted brood size analysis
using animals fed RNAi to a control gene, wee-1.3 alone, cdk-7 alone,
wee-1.3 plus cdk-7, or wee-1.3 plus the control gene (Figure 5B). For
these experiments, we deﬁne a brood as the total number of embryos
laid and larvae hatched on a given plate. The average brood size for
animals fed control(RNAi) was 172 compared with 0.6 for animals fed
wee-1.3(RNAi). cdk-7(RNAi) by itself results in an average brood size
of 158; however, that entire brood is comprised of multi-cellular
arrested embryos compared with the broods of viable progeny observed
on control(RNAi) treatment (Figure 5B). Co-depletion of WEE-1.3 and
CDK-7 via RNAi feeding returns the brood size to a wild-type level
(average brood = 157), and the entire brood consists of multi-cellular
embryos (Figure 5B). In contrast, co-depletion of WEE-1.3 and a control
gene resulted in an average brood of nine viable progeny (Figure 5B).
We then examined the gonads of animals co-depleted of WEE-1.3
and CDK-7 by immunoﬂuorescence using antibodies to known oocyte
maturation markers (Burrows et al. 2006) to determine if the gonads
exhibited precociously matured oocytes (Figure 5, C–H; individual
panels of antibody staining can be found in Figure S3). Maturing
oocytes exhibit a condensed chromatin state that can be monitored
by staining with an antibody speciﬁc for phosphorylated histone H3 at

serine 10 (pH3) (Hendzel et al. 1997; Hsu et al. 2000). In addition,
mature oocytes lack a nucleolus, and the absence or presence of a
nucleolus can be visualized by using an antibody to the nucleolar
marker Nop1p/ﬁbrillarin (Aris and Blobel 1988; Henriquez et al.
1990; Schimmang et al. 1989). Animals fed RNAi to a control gene
exhibited a wild-type pattern of pH3 and Nop1p expression. Nop1p
staining was absent in the nuclei of the 21 and 22 oocytes, whereas
the pH3 antibody stained the nuclei and chromosomes of the three
most proximal oocytes within each gonad arm (Figure 5C). As previously reported, wee-1.3(RNAi) animals contain precociously maturing
oocytes when compared with control(RNAi) animals (Burrows et al.
2006). This is characterized by an increased number of pH3–positive
oocyte nuclei and a decreased number of Nop1p-positive oocyte nuclei
(Figure 5D). Depletion of CDK-7 via RNAi feeding did not alter the
expression pattern of either pH3 or Nop1p when compared with control
(RNAi) animals (Figure 5E). Co-depletion of both WEE-1.3 and CDK-7
suppressed the precocious oocyte maturation phenotype exhibited by
depletion of WEE-1.3 alone and returned the gonad to a more wild-type
expression pattern, with the three to four most proximal oocytes being
pH3-positive and Nop1p-negative (Figure 5H). Co-depletion of either
WEE-1.3 or CDK-7 in combination with a control protein did not
change the expression pattern of pH3 and Nop1p within the gonads
when compared with single depletion of WEE-1.3 or CDK-7 (Figure
5F-G). Therefore, suppression of the precocious oocyte maturation
caused by wee-1.3(RNAi) is speciﬁc to cdk-7(RNAi).
DISCUSSION
In this study, we further characterized the precocious oocyte maturation
observed in WEE-1.3–depleted animals and identiﬁed a number of

Figure 5 Co-depletion of WEE-1.3 and CDK-7 suppresses the infertility phenotype of WEE-1.3 depletion. (A) Schematic on how CDK-7 (CAK or
Cdk-activating kinase) and WEE-1.3 (inhibitory kinase) act on maturation promoting factor (MPF) to regulate the activity of MPF. (B) Average brood
size per mother treated with control RNAi, wee-1.3 RNAi, cdk-7 RNAi, or co-depleted of wee-1.3 and cdk-7 RNAi or wee-1.3 and control RNAi.
Each bar represents the average of four independent experiments with three animals per experiment (n = 12), and the error bars represent SEM.
(C–H) Single-plane confocal images of gonads dissected from mothers treated with the indicated RNAi, ﬁxed, and co-stained with antibodies
against phosphohistone H3 (Ser10) (pH3, green), nucleolus (Nop1p, red), and DNA (DAPI, blue). RNAi treatment is as follows: (C) control; (D) WEE1.3–depleted; (E) CDK-7–depleted; (F) co-depletion of WEE-1.3 and control; (G) co-depletion of CDK-7 and control; and (H) co-depletion of WEE1.3 and CDK-7. Gonads are oriented with the proximal region to the right in this ﬁgure. Scale bar is approximately 20 mm. Individual panels of
Nop1p and pH3 antibody staining can be found in Figure S3.
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interactors with WEE-1.3 through a large-scale RNAi suppressor screen.
Our ﬁndings suggest that upon WEE-1.3 depletion by RNAi, the oocytes
of the treated animals prematurely relocalize proteins to resemble the
pattern frequently observed during early embryogenesis. These oocytes
also undergo precocious embryonic gene activation. The suppressor
screen successfully identiﬁed 44 potential interactors with WEE-1.3,
which are targets for future analysis.
The expression of WEE-1.3 in the proximal germline within developing oocytes supports a role for WEE-1.3 in oocyte maturation. In
addition, the ubiquitous expression of WEE-1.3 throughout multiple
tissues types, including the soma of the adult worm and the developing embryo, suggests that WEE-1.3 may have previously unidentiﬁed
roles in the somatic tissues, presumably to regulate other processes
besides oocyte maturation. Supporting the idea of zygotic roles for
WEE-1.3 in embryonic development are unpublished observations by
our laboratory that null mutants of wee-1.3(ok729) can give rise to
homozygous progeny that are predominantly late embryonic lethal
and rare L1 larval lethal animals.
WEE-1.3 is predicted to be a transmembrane protein, and our
results show that WEE-1.3 is localized to a perinuclear position in
both germline and somatic tissues. This localization ﬁts nicely with the
current known role for WEE-1.3, because this protein has been shown
to interact with CDK-1, and CDK-1 is a protein that shuttles between
the cytoplasm and the nucleus to regulate its target genes. Having
WEE-1.3 positioned on the nuclear periphery places that protein in
the ideal location to regulate CDK-1. Meanwhile, the diffuse cytoplasmic punctate expression of WEE-1.3 and co-localization with known
endoplasmic reticulum markers suggests that there might be other
proteins with which WEE-1.3 interacts and regulates. Our described
localization pattern is similar to those reported for orthologs of the
Myt1/Wee1 family of kinases in mouse, Drosophila, and humans. In
mouse isolated GV oocytes, WEE1B was found throughout the nucleus,
whereas Myt1 exhibited a punctate pattern throughout the cytoplasm and
was excluded from the nucleus (Oh et al. 2010). Meanwhile, in Drosophila S2 cells, dMyt1 subcellular localization was shown to overlap with
Golgi markers (Cornwell et al. 2002). Furthermore, in HeLa cells, human
Myt1 was localized to the ER and Golgi complex (Liu et al. 1997).
The observed diakinetic chromosome coating exhibited by the
WEE-1.3 antibody is extremely intriguing and provides evidence for a
potential new role for this particular inhibitory kinase. In the initial
studies of WEE-1.3–depleted animals, it was demonstrated that the
oocyte chromosomes do not maintain a diakinetic arrangement, but
rather coalesce and over-congress into a single mass of chromatin
(Burrows et al. 2006). This implied that there was some required role
for WEE-1.3 in maintenance of mature oocyte chromosome structure.
Our studies help to conﬁrm this role and provide the basis for a potential
mechanism by which WEE-1.3 could be involved in this maintenance.
Because WEE-1.3 was shown to coat all of the diakinetic chromosomes
in wild-type animals, we propose that WEE-1.3 is necessary for the
individualization of the chromosomes in the mature oocytes and, thus,
in the absence of WEE-1.3, the chromosomes amalgamate to form one
single structure. This is an area we are actively investigating.

relocalization in the oocytes of WEE-1.3–depleted animals (Burrows
et al. 2006; Cheng et al. 2009; Stitzel et al. 2007). Our additional observations of PGL-1 and OMA-1 exhibiting premature relocalization and
degradation upon WEE-1.3 depletion demonstrate that the redistribution and degradation of these two proteins are dependent on meiotic
maturation and not fertilization. Alternatively, this altered localization
could be the result of embryonic gene activation. The premature expression of CBD-1::mCherry in WEE-1.3–depleted oocytes provides the
ﬁrst indication regarding why those oocytes might be fertilizationincompetent and wee-1.3(RNAi) results in infertility. With the oocytes
prematurely expressing a component of the eggshell, this could potentially inﬂuence the competency for fertilization in the WEE-1.3–
depleted oocytes. It will be interesting to determine if other recently
discovered components of the eggshell are also prematurely expressed
in oocytes of WEE-1.3–depleted animals (Olson et al. 2012).
Early gene activation (EGA) of embryonic transcripts was also
observed in WEE-1.3–depleted animals. Two of the earliest known
transcribed mRNAs in C. elegans (vet-1 and vet-4) were shown to have
an increased abundance in the germline upon wee-1.3(RNAi) treatment. Because the germlines were normalized to control RNAi-treated
germlines, and because the only difference was the presence of precociously maturing oocytes, the data imply that the normally quiescent
oocytes have induced embryonic-like transcription. The fact that not all
transcripts are prematurely activated (e.g., vet-6 mRNA) is not surprising due to the fact that we showed that while the OTE transition has
occurred prematurely with respect to a number of proteins (e.g., MBK-2
and CHS-1), complete OTE has not occurred. Namely, we did not
observe premature relocalization of CAV-1 in the precociously maturing oocytes, nor did we observe the formation of a chitinous eggshell. In
addition, there is no reason to believe that the precocious oocytes have
begun to transcribe every embryonic gene.
The connection between the meiotic cell cycle and precocious EGA
has not been previously observed. However, Biedermann et al. (2009)
recently demonstrated a link between the mitotic cell cycle and EGA
in C. elegans. They reported that loss of GLD-1 in the germline
resulted in ectopic activation of Cyclin E (CYE-1) and CDK-2 and
premature onset of embryonic-like transcription or EGA. The authors
proposed that the precocious EGA might be due to CYE-1/CDK-2
activating a transcription factor involved in EGA. The precise mechanism(s) by which EGA is controlled is not well-understood, but
studies in different model systems have implicated degradation of
maternal mRNAs, repression of basic transcription factors, and induction of gene expression through a sequence-speciﬁc transcription
factor (Guven-Ozkan et al. 2008; Liang et al. 2008; Tadros et al. 2007).
In addition, it has been shown that activation of CDK2 by maternal
cyclin A2 is required for EGA in the one-cell mouse embryo (Hara
et al. 2005). How does depletion of WEE-1.3 result in precocious
EGA? We propose that the absence of WEE-1.3 might result in premature activation of CDK-1 in the oocytes. This would lead to the
inappropriate activation of the target genes of CDK-1 in the oocytes.
Normally, CDK-1 would be held inactive in the oocytes, and the target
genes only activated in the fertilized embryos.

WEE-1.3 depletion causes premature relocalization of
embryonic proteins and early gene activation within the
precociously maturing oocytes
The initiation of development upon fertilization, whereby a quiescent
oocyte transitions into a dynamic embryo capable of differentiating
into multiple cell types, is marked by the relocalization or degradation
of a number of maternal proteins. Some of these proteins (e.g., MBK-2,
EGG-3, and CHS-1) have been previously reported to exhibit premature

Identiﬁcation of suppressors of the WEE-1.3 depletion
phenotype through an RNAi screen
The RNAi suppressor screen allowed us to identify many genes that
resulted in a restoration of fertility when co-depleted with WEE-1.3.
The mechanism of suppression remains to be determined and is a
focus of future investigation. In total, we identiﬁed 44 potential interactors with WEE-1.3 that had not been previously predicted or shown
to physically interact. Importantly, we had more than 1600 internal
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controls that did not suppress the WEE-1.3 depletion infertility when
co-depleted along with wee-1.3, suggesting that the effects we see after
phase 2 of the screen are real and not due to simple dilution effects. In
addition, we performed dilution analysis of the effectiveness of codiluted wee-1.3(RNAi) with a control RNAi that does not affect fertility (smd-1), and we found that diluting wee-1.3 by ﬁve-fold does not
alter the observed infertility phenotype (data not shown).
Interestingly, of the 38 predicted and/or conﬁrmed interactions
identiﬁed on WormBase for WEE-1.3, we tested 16 (42%) in our screen
and found 3 (8%) that acted as suppressors of WEE-1.3 depletion infertility. In addition, one of the suppressors, IMB-2, had been shown to
interact via two-hybrid studies by Boxem et al. (2008), and our data
provide support that this interaction also occurs in vivo. We note that,
because these candidates were identiﬁed through a genetic screen, it is
possible that many are functioning indirectly with WEE-1.3 to cause
suppression of the infertility phenotype.
We initially chose to screen only the RNAi library clones that had
been previously characterized as embryonic lethals on the assumption
that any WEE-1.3 interactors would be essential genes. Interestingly,
of the 1874 Emb clones we screened through feeding, a number of the
suppressors were not embryonic lethal by RNAi feeding, yet they
suppressed the WEE-1.3 depletion infertility. This includes most of
the strong suppressors. The fact that these clones were not Emb in our
experiments can be explained by the fact that, as previously noted, the
genes screened were ones reported as having an Emb phenotype in
WormBase through any RNAi assay (feeding, injecting, soaking, feeding in a sensitized strain background). Thus, a stronger method of RNAi
other than feeding may be required to observe the Emb phenotype of
that gene. In addition, this implies that a genome-wide RNAi screen
might identify even more candidate suppressors.
The bioinformatics analysis of gene ontologies conducted on our
list of suppressors enabled us to extract functionally relevant biology
from the large gene list. Although many suppressors were cell cycle–
related, a number failed to fall into that category; thus, this screen has
potentially identiﬁed non-cell cycle functions of WEE-1.3 or potentially
has identiﬁed genes that have previously unidentiﬁed roles in the cell
cycle. A number of components of the proteasome were identiﬁed as
suppressing the wee-1.3(RNAi) infertility phenotype, indicating the importance that appropriate protein degradation has in the germline, especially in oocyte maturation.
Because RNAi provides a very unique window of protein depletion,
which may or may not result in a complete lack of the targeted gene
product, our screen potentially identiﬁed many suppressor candidates
that would have been difﬁcult to identify if screening a mutant collection
for suppression. We have begun to conﬁrm whether genetic mutants of
identiﬁed suppressors also suppress the WEE-1.3 depletion phenotype.
Preliminary data indicate that some, but not all, mutants can suppress
the wee-1.3(RNAi) infertility to a level similar to that observed upon
RNAi depletion of the candidate (data not shown).
Finally, it is worth pointing out that the suppressors identiﬁed in this
screen might potentially be acting as direct regulators of CDK-1. For
example, suppressors that alter the trafﬁcking or localization of CDK-1
could result in suppression of the WEE-1.3 depletion infertility. We
hypothesize that if CDK-1 is prevented from translocating to the nucleus,
then the CDK-1 target genes would no longer be erroneously activated,
and this might prevent the precociously maturing oocytes. The suppressor
IMB-2, a member of the importin beta family of proteins that bind and
transport proteins into the nucleus, might be functioning in this manner
(Adam 2009). Co-depletion of WEE-1.3 and IMB-2 could potentially
result in precociously activated CDK-1; however, due to the absence of
IMB-2, the activated CDK-1 cannot translocate to the nucleus.

The suppressor CDK-7 (Figure 5) is most likely suppressing
through its action on CDK-1 and not directly by interacting with
WEE-1.3. CDK-7 is the CDK activating kinase (CAK) involved in
positively phosphorylating the CDK component of maturation promoting factor (MPF). This activating phosphorylation is essential for the
proper activity level of MPF. By depleting both CDK-7 and WEE-1.3,
the level of active MPF might be modulated such that there is enough
functionally active MPF to alleviate meiotic arrest and continue with the
meiotic cell cycle.
In summary, our studies have determined the in vivo distribution
of WEE-1.3, the C. elegans Wee1/Myt1 ortholog, and further characterized the WEE-1.3 depletion phenotype. We have shown that the
precocious oocyte maturation observed upon WEE-1.3 depletion results
not only in the premature relocalization of maternal proteins but also in
the premature appearance of an eggshell component and in embryonic
gene activation. Finally, we have identiﬁed a large number of potential
interactors and/or regulators of WEE-1.3 through an RNAi suppressor
screen. This screen has generated a rich resource for future inquiry into
the studies of cell cycle regulation and, speciﬁcally, oocyte maturation.
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